December 2018 | Volume 2
As the year winds down, we all find ourselves reviewing changes and trends from 2018 and predicting what lies ahead. The challenges of balancing our healthcare system’s approach to ensuring access, quality and reasonable cost have never been higher-stakes. Value has emerged as a synonym for the Triple Aim. And yet, we have not achieved consensus on how to measure value and how to achieve it for both healthy and chronically ill individuals. In this final edition of the year, articles highlight this continued tension and also forecast key themes for 2019. We are at a tipping point, with an opportunity to leverage greater technology, a learning healthcare system and a more aware (and active?) patient community. If patient-centered healthcare is truly our objective, we need to involve innovators, data generators and owners, researchers, clinicians and patients (in all their individual and organizational configurations) to help define the value in healthcare we want to achieve. Happy Holidays!
Patient Perspectives Must Meaningfully Inform Healthcare Value Measurement  
The United States has the most expensive healthcare system in the world, as well as a growing number of patients living with chronic illnesses. Further, there is an ever-expanding number of available treatment options, many of which have limited differences in efficacy and toxicity.
Value-Based Pricing And Reimbursement: Still More Promise Than Reality  
Value in healthcare is measured in terms of the patient outcomes achieved per dollars spent. As such, when policymakers measure the output of healthcare systems it's not the volume of services delivered that matters, but rather the outcomes.
NHC Publishes White Paper on Overcoming Barriers to Amplify the Patient Voice in Value Assessment
The National Health Council (NHC) published last week our latest white paper, A Dialogue on Patient-Centered Value Assessment: Overcoming Barriers to Amplify the Patient Voice , which outlines recommendations to enhance patient centricity in value assessment.
Why providers need to consider patient perspective when addressing diagnostic errors  
Diagnostic errors are a significant contributor to patient harm. To address the problem, providers need to spend more time listening to patients’ experiences, according to a new study.
Ban Ki-moon: Only Two Healthcare Systems Exist—One Where The Rich Pay For The Poor, and America's  
Health is a human right. When people are not able to access the healthcare they need, especially if this is for reasons of cost, their human rights are denied. It is vital for the wider fight for rights, justice and sustainable development that policymakers’ actions are informed by this linkage.
Big Data pushing democratization of healthcare, but barriers remain  
Big Data is changing healthcare, giving doctors new tools to diagnose and treat patients and creating new opportunities for patients to participate in their own health. The report notes the Apple Heart Study, a Stanford and Apple collaboration, is recruiting 400,000 people to study how accurately Apple Watch detects atrial fibrillation.
Dr. Mark Smith’s Five Tasks for the Healthcare Sector  
A good keynote address gets us to challenge our assumptions and consider some new possibilities in our field, often bringing in ideas from other disciplines or markets. That is what Mark Smith, M.D., M.B.A. founding president and CEO of the California Health Care Foundation, did last week at the annual meeting of the Patient Centered Outcomes Research Institute (PCORI) in Washington, D.C.
Civica Rx's first CEO, Martin VanTrieste, talks about the company's ambitions for 2019 and beyond
When Martin VanTrieste left his executive role at Amgen, he said he was retiring.
He’d started out as a pharmacist, working in formulation development for a large pharmaceutical company, and went on to ultimately become the chief quality officer of a drug giant.
Why Don’t We Have Vaccines Against Everything?
Vaccines are among the most ingenious of inventions, and among the most maddening.
Some global killers, like smallpox and polio, have been totally or nearly eradicated by products made with methods dating back to Louis Pasteur. Others, like malaria and H.I.V., utterly frustrate scientists to this day, despite astonishing new weapons like gene-editing.  

Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534